Questionnaire based survey of Psychiatrists to know their treatment options for Bipolar Disorders
Not Applicable
Completed
- Registration Number
- CTRI/2014/11/005213
- Lead Sponsor
- Glaxosmithkline Pharmaceuticals Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
1.Psychiatrists (with postgraduate degree/diploma/fellowship in psychiatry) practicing for at least 3 years after post graduation in India.
2.Psychiatrists willing to sign the consent form
3.Psychiatrists willing to complete the survey
Exclusion Criteria
1. Psychiatrists practicing for fewer than 3 years after post graduation in India.
2.Psychiatrists not willing to sign the consent form
3.Psychiatrists not willing to complete the survey questionnaire
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The usage pattern of pharmacological and non-pharmacological interventions by Psychiatrists practicing in India for bipolar disordersTimepoint: 2 months
- Secondary Outcome Measures
Name Time Method 1.Determination of gaps (if any) in CANMAT guidelines and treatment chosen in the clinical practice in India <br/ ><br>2.Determination of the extent of use of antidepressants in bipolar disorder by psychiatrists practising in India <br/ ><br>3.Determination of the role of Psychoeducation, Interpersonal and Social Rhythm Therapy or ECT in BPD by psychiatrists practising in India <br/ ><br>Timepoint: 2 months